Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
The authoritative guide to the revolutionary concept behind the successful Covid-19 vaccines In Trends in mRNA Vaccine Research , a team of distinguished researchers delivers a practical and up-to-date discussion of the biochemical and biomedical foundations of mRNA vaccines. They also explore the manufacturing conditions required for successful vaccine development and review recent progress in a variety of medical fields, including vaccines against pathogens like SARS-CoV-2, HIV, plasmodium, Mycobacterium tuberculosis , as well as anticancer vaccines. Volume highlights include: A…mehr
The authoritative guide to the revolutionary concept behind the successful Covid-19 vaccines
In Trends in mRNA Vaccine Research, a team of distinguished researchers delivers a practical and up-to-date discussion of the biochemical and biomedical foundations of mRNA vaccines. They also explore the manufacturing conditions required for successful vaccine development and review recent progress in a variety of medical fields, including vaccines against pathogens like SARS-CoV-2, HIV, plasmodium, Mycobacterium tuberculosis, as well as anticancer vaccines.
Volume highlights include:
A historical overview of mRNA vaccine development
Immune responses to modified or unmodified mRNA vaccines
A description of the different mRNA vaccine platforms
Latest data on current mRNA vaccine developments against infectious diseases and cancer
Perfect for medicinal chemists, immunologists, and epidemiologists, Trends in mRNA Vaccine Research will also benefit researchers and scientists working in the pharmaceutical industry, as well as cancer researchers with an interest in vaccine development.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in D ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Gabor Tamas Szabo, MD, PhD, is an Associate Director at BioNTech SE. His work is focused on mRNA technology optimization and applications. Norbert Pardi, PhD, is an Assistant Professor at the University of Pennsylvania, USA. His research is focused on the development of mRNA-based therapeutics with a focus on vaccines.
Inhaltsangabe
PART I: HOW mRNA VACCINES WORK A Historical Overview on mRNA Vaccine Development Immune Responses to mRNA Vaccines Modified or Unmodified mRNA Vaccines? - The Biochemistry of Pseudouridine in mRNA Vaccines Self-replicating RNA Viruses for Vaccine Development Circular RNA Therapeutics and Vaccines GMP and Up-scaling of mRNA Vaccine Production mRNA Vaccination for Induction of Immune Tolerance Against Autoimmune Disease
PART II: RECENT PROGRESS IN VACCINE RESEARCH AND DEVELOPMENT Approved mRNA Vaccines Against SARS-CoV-2 mRNA Vaccines for HIV-1 mRNA Vaccines Against Tick-borne Diseases mRNA Vaccines for Malaria and Other Parasitic Pathogens mRNA Vaccines Against Mycobacterium tuberculosis Cancer Vaccines Based on mRNA: Hype or Hope?
PART I: HOW mRNA VACCINES WORK A Historical Overview on mRNA Vaccine Development Immune Responses to mRNA Vaccines Modified or Unmodified mRNA Vaccines? - The Biochemistry of Pseudouridine in mRNA Vaccines Self-replicating RNA Viruses for Vaccine Development Circular RNA Therapeutics and Vaccines GMP and Up-scaling of mRNA Vaccine Production mRNA Vaccination for Induction of Immune Tolerance Against Autoimmune Disease
PART II: RECENT PROGRESS IN VACCINE RESEARCH AND DEVELOPMENT Approved mRNA Vaccines Against SARS-CoV-2 mRNA Vaccines for HIV-1 mRNA Vaccines Against Tick-borne Diseases mRNA Vaccines for Malaria and Other Parasitic Pathogens mRNA Vaccines Against Mycobacterium tuberculosis Cancer Vaccines Based on mRNA: Hype or Hope?
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826